These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7277389)
1. N-Aralkyl substitution of 2-amino-5,6- and -6,7-dihydroxy-1,2,3,4-tetrahydronaphthalenes. 1. Cardiac and pressor/depressor activities. Gorczynski RJ; Anderson WG; Stout DM J Med Chem; 1981 Jul; 24(7):835-9. PubMed ID: 7277389 [TBL] [Abstract][Full Text] [Related]
2. N-Aralkyl substitution of 2-amino-5,6- and -6,7-dihydroxy-1,2,3,4-tetrahydronaphthalenes. 2. Derivatives of a hypotensive-positive inotropic agent. Stout DM; Gorczynski RJ J Med Chem; 1982 Mar; 25(3):326-8. PubMed ID: 7069709 [TBL] [Abstract][Full Text] [Related]
3. N-aralkyl substitution of 2-aminoindans. Synthesis and their inotropic and chronotropic activity in isolated guinea pig atria. Pérez JA; Domínguez JN; Angel JE; Duerto de Pérez Z; Salazar-Bookaman MM; Acosta H; Charris JE Arzneimittelforschung; 1997 Nov; 47(11):1208-10. PubMed ID: 9428975 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the cardiac stimulant properties of (3,4-dihydroxyphenyl)-cyclopropylamine (ASL-7003) and 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (A6,7DTN). Gorczynski RJ; Anderson WG; Erhardt PW; Stout DM J Pharmacol Exp Ther; 1979 Aug; 210(2):252-8. PubMed ID: 222894 [No Abstract] [Full Text] [Related]
5. Cardiovascular pharmacology of ASL-7022, a novel catecholamine. I. Inotropic, chronotropic and pressor actions. Gorczynski RJ J Pharmacol Exp Ther; 1982 Oct; 223(1):7-11. PubMed ID: 7120130 [TBL] [Abstract][Full Text] [Related]
6. Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution. Kohli JD; Goldberg LI; McDermed JD Eur J Pharmacol; 1982 Jul; 81(2):293-9. PubMed ID: 6126371 [TBL] [Abstract][Full Text] [Related]
7. Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene, IX: Structure-activity relationships of cis- and trans-2-amino-5,8-dimethoxytetralin-3-ols and some analogues. Christova K; Dantchev D; Staneva D; Rainova L Arch Pharm (Weinheim); 1984 Oct; 317(10):829-34. PubMed ID: 6517670 [No Abstract] [Full Text] [Related]
8. [Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene, VII: Aroyl esters of cis- and trans-2-dimethylamino-3-hydroxy-5,8-dimethoxy-1,2,3,4-tetrahydronaphthalenes]. Christova K; Dantschev D; Rainova L; Staneva D Arch Pharm (Weinheim); 1982 Sep; 315(9):797-801. PubMed ID: 7138245 [No Abstract] [Full Text] [Related]
9. 5,7-Dihydroxy-2-aminotetralin derivatives: synthesis and assessment of dopaminergic and adrenergic actions. Cannon JG; Brubaker AN; Long JP; Flynn JR; Verimer T; Harnirattisai P; Costall B; Naylor RJ; Nohria V J Med Chem; 1981 Feb; 24(2):149-53. PubMed ID: 7205882 [TBL] [Abstract][Full Text] [Related]
10. The syntheses and beta-adrenoceptor activities of N-substituted 2-amino-5,6-dihydroxy-1,2,3,4-tetrahydro-1-naphthalenols. Itoh K; Motohashi M; Kuriki H; Sugihara H; Inatomi N; Nishikawa M; Oka Y Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):2917-28. PubMed ID: 23906 [No Abstract] [Full Text] [Related]
11. Syntheses of 1,2-N-alkylimino-1,2,3,4-tetrahydronaphthalene derivatives and preparation of ring closed analog of salbutamol as a new beta-adrenoceptor agent. Sugihara H; Ukawa K; Miyake A; Itoh K; Sanno Y Chem Pharm Bull (Tokyo); 1978 Feb; 26(2):394-404. PubMed ID: 25142 [No Abstract] [Full Text] [Related]
12. Dopamine vascular actions of N-substituted derivatives of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN). Kohli JD; Goldberg LI; Nichols DE Eur J Pharmacol; 1979 Jun; 56(1-2):39-44. PubMed ID: 467513 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the inotropic: chronotropic selectivity of dobutamine and dopamine in anaethetised dogs and guinea-pig isolated atria. Lumley P; Broadley KJ; Levy GP Cardiovasc Res; 1977 Jan; 11(1):17-25. PubMed ID: 12867 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 2-(N-substituted amino)-6-hydroxy-1,2,3,4-tetrahydronaphthalen-1-ol derivatives. Miyake A; Itoh K; Tada N; Tanabe M; Hirata M; Oka Y Chem Pharm Bull (Tokyo); 1983 Jul; 31(7):2329-48. PubMed ID: 6139177 [No Abstract] [Full Text] [Related]
15. C(2)-Methylation abolishes DA1 dopamine agonist activity of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN): steric intolerance by the receptor. Nichols DE; Jacob JN; Hoffman AJ; Kohli JD; Glock D J Med Chem; 1984 Dec; 27(12):1701-5. PubMed ID: 6502600 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and beta-adrenergic blocking activity of 2-(N-substituted amino)-1,2,3,4-tetrahydronaphthalen-1-ol derivatives. Itoh K; Miyake A; Tada N; Hirata M; Oka Y Chem Pharm Bull (Tokyo); 1984 Jan; 32(1):130-51. PubMed ID: 6144399 [No Abstract] [Full Text] [Related]
17. Cardiovascular pharmacology of ASL-7022. II. Mechanisms of inotropic selectivity. Gorczynski RJ; Wroble RW J Pharmacol Exp Ther; 1982 Oct; 223(1):12-9. PubMed ID: 6126579 [TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanism of action of 1-(2-methyl-3-hydroxy-5-hydroxy-methyl-4-pyridyl)-6,7-dihydroxy-1,2,3, 4- tetrahydroisoquinoline (PTIQ) on blood pressure in the anesthetized dog. Siu PM; Vick JA Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):421-33. PubMed ID: 2781139 [TBL] [Abstract][Full Text] [Related]
19. Syntheses and beta-adrenoceptor activities of 2-alkylamino-6-hydroxy-5-hydroxymethyl-1,2,3,4-tetrahydro-1-naphthalenols. Sugihara H; Ukawa K; Kuriki H; Nishikawa M; Sanno Y Chem Pharm Bull (Tokyo); 1977 Nov; 25(11):2988-3002. PubMed ID: 23907 [No Abstract] [Full Text] [Related]
20. Cardioselective antimuscarinic action of a dopamine receptor agonist, N,N-dipropyl-2-aminotetralin (TL-68). Sahin I; Ilhan M Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):185-92. PubMed ID: 3446046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]